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Porcine reproductive and respiratory syndrome virus (PRRSV) infection of swine leads to a serious
disease characterized by a delayed and defective adaptive immune response. It is hypothesized that a
suboptimal innate immune response is responsible for the disease pathogenesis. In the study presented
here we tested this hypothesis and identified several nonstructural proteins (NSPs) with innate immune
evasion properties encoded by the PRRS viral genome. Four of the total ten PRRSV NSPs tested were
found to have strong to moderate inhibitory effects on beta interferon (IFN-) promoter activation. The
strongest inhibitory effect was exhibited by NSP1 followed by, NSP2, NSP11, and NSP4. We focused on
NSP1 and NSP1 (self-cleavage products of NSP1 during virus infection) and NSP11, three NSPs with
strong inhibitory activity. All of three proteins, when expressed stably in cell lines, strongly inhibited
double-stranded RNA (dsRNA) signaling pathways. NSP1 was found to inhibit both IFN regulatory
factor 3 (IRF3)- and NF-B-dependent gene induction by dsRNA and Sendai virus. Mechanistically, the
dsRNA-induced phosphorylation and nuclear translocation of IRF3 were strongly inhibited by NSP1.
Moreover, when tested in a porcine myelomonocytic cell line, NSP1 inhibited Sendai virus-mediated
activation of porcine IFN- promoter activity. We propose that this NSP1-mediated subversion of the
host innate immune response plays an important role in PRRSV pathogenesis.
Porcine reproductive and respiratory syndrome virus
(PRRSV) is a member of family Arteriviridae which, along with
the Coronaviridae, are classified in the order Nidovirales (9).
PRRSV is an enveloped, single-stranded RNA virus with pos-
itive-sense genome of 15 kb. The genome has nine open
reading frames (ORFs), namely, ORF1a, ORF1b, ORF2a,
ORF2b, and ORF3-7. ORF1a and ORF1b are synthesized as a
single polyprotein and later processed to 14 different nonstruc-
tural proteins (NSPs), e.g., NSP1, NSP1, and NSP2 to
NSP12 by the viral proteases. NSP1, NSP1, NSP2, and NSP4
are the viral proteases which carry out this function. The viral
genome replication and transcription is carried out by NSP9,
which encodes the viral RNA-dependent RNA polymerase,
and NSP10, which encodes a helicase (5, 49).
The ailment caused by PRRSV is considered to be the most
economically significant infectious disease of swine worldwide.
It causes an annual loss of approximately $560 million in the
United States (38). The clinical signs of PRRSV infection
include late-term reproductive failure in sows and respiratory
illness in growing pigs. Most cases of PRRSV infection in pigs
are complicated by secondary opportunistic bacterial infec-
tions, which have been attributed to the immunosuppressive
nature of the virus (13). Upon initial virus infection, viremia
lasts for a few weeks, after which it resolves. However, the virus
can be detected in secondary lymphoid organs for several
months, indicating failure of host immune response to clear the
virus (2).
The immune response to PRRSV infection is characterized
by a delayed appearance of neutralizing antibodies (31), a
short cell-mediated immune response (34, 59), and slow devel-
opment of a virus-specific gamma interferon (IFN-) response
(35). We and others have identified various factors that are
likely to play multiple roles in delayed clearance of PRRSV
from the host. These include weak innate immune response (1,
35), presence of decoy epitopes (39), and glycan shielding of
envelope proteins (3). Previous studies have shown that very
low or negligible levels of IFN- are produced upon PRRSV
infection in pulmonary alveolar macrophages (PAMs) and
PRRSV permissive monkey kidney cells (MARC-145) in vitro
(1, 36). IFN- production in the lungs of pigs acutely infected
with PRRSV was either almost undetectable or 100- to 200-
fold lower than that induced by porcine respiratory coronavi-
rus (PRCV) (8, 57). PRRSV has also been found to suppress
IFN- production by transmissible gastroenteritis corona virus
(TGEV), a known inducer of IFNs in infected alveolar mac-
rophages (1). At the same time, externally provided IFN- or
IFN- have been able to reduce viral replication in cultured
alveolar macrophages (1, 40). The virus was also found to
inhibit the dsRNA-mediated upregulation of IFN- gene tran-
scription (36). A microarray analysis of PAMs infected with
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Lelystad virus (European type PRRSV) showed no significant
change in the IFN- from the control at 12 h postinfection
(17). Considering the broad role of IFNs in establishing an
effective adaptive immune response, we hypothesize that the
suboptimal induction of type I IFN may be one of the deter-
mining factors in deficient development of acquired immunity.
In the constant struggle to outsmart the host, viruses have
developed strategies to evade and/or inhibit key elements of
host immune response. Sometimes, a substantial part of the
viral genome is dedicated toward suppressing IFN signaling
pathways, IFN-stimulated gene (ISG) functions, or pathways
for RNA processing and translation (7, 16). In the present
study we sought to identify the PRRSV proteins that are re-
sponsible for mediating the inhibition of IFN production. We
observed that several PRRSV NSPs inhibit IFN regulatory
factor 3 (IRF3)-mediated activation of IFN- promoter. De-
tailed investigation of the mechanism of inhibition of one of
those viral proteins, NSP1, revealed that it inhibits double-
stranded RNA (dsRNA)-mediated IRF3 phosphorylation and
nuclear translocation.
MATERIALS AND METHODS
Cells and viruses. HEK293-TLR3 (Invivogen), HeLa (American Type Culture
Collection [ATCC]), HT1080 (ATCC), MARC-145 (obtained from Will Lae-
greid, USMARC, USDA/ARS) (25), and ST (ATCC) cells were maintained in
Dulbecco modified Eagle medium (DMEM) containing 10% fetal bovine serum
and 50 g of gentamicin (Sigma)/ml. HEK293-TLR3 and HT1080 cells stably
expressing PRRSV NSP1, NSP1, and NSP11 were established by cotransfect-
ing them with corresponding PRRSV protein expression plasmid and pBabe-
Puro. After selection with 1 g of Puromycin (Mediatech)/ml, individual colonies
were picked and screened for stable expression of PRRSV NSPs. For the swine
macrophage experiments, mononuclear cells were isolated from blood of donor
pigs by Ficoll density centrifugation using lymphocyte separation medium (Me-
diatech) (32). These cells were then plated in a glass petri dish for 1 day, followed
by washing with phosphate-buffered saline (PBS) to enrich the monocytes. The
attached monocytes were cultured in RPMI 1640 medium supplemented with
10% BVDV-free fetal bovine serum in the presence of the growth factor mac-
rophage colony-stimulating factor (5 ng/ml) (Sigma) for 7 days for maturation
into macrophages. These monocyte-derived macrophages were then harvested by
cell dissociation buffer (Gibco) and plated in appropriate tissue culture plate
with RPMI 1640 and 10% fetal bovine serum (FBS) for virus infection. Porcine
monocytic cell line 3D4/31 (ATCC) was maintained in RPMI 1640 medium
supplemented with 10% BVDV-free fetal bovine serum and 50 g of gentamicin
(Sigma)/ml. Highly virulent North American PRRSV strain FL12 (56) was prop-
agated in MARC-145 cells to prepare the virus stocks for the present study.
TGEV (Purdue strain) (1) was obtained from the Veterinary Diagnostic Center
(University of Nebraska) and propagated in ST cells to prepare the virus stocks
for infection in macrophages. Sendai virus (SeV; Cantell strain) was obtained
from Charles River Laboratories and was used as described below.
Reporter assays. IFN--CAT assays were performed in HeLa cells transfected
with 1 g of IFN--CAT reporter plasmid, 0.5 g of IRF3 plasmid (Luwen
Zhang, University of Nebraska), and 1 g of indicated viral protein coding
plasmid using Lipofectamine-2000 (Invitrogen) according to the manufacturer’s
instructions. At 40 h posttransfection, the cells were lysed by freeze-thawing, and
a chloramphenicol acetyltransferase (CAT) assay was performed as described
earlier (44). CAT activity is expressed as the fold induction relative to the empty
vector control. A minimum of three independent experiments was performed to
confirm the results. For ISG56-luciferase reporter assays, HEK293-TLR3 cells
were transfected with 0.4 g of ISG56-luciferase reporter plasmid and 10 ng of
pRL-TK (Promega), along with the indicated protein expression vectors using
Fugene 6 (Roche Applied Science) according to the manufacturer’s protocol.
For the NF-B luciferase assays, HEK293-TLR3 cells were transfected with 0.5
g of 5X-NF-B-luciferase reporter plasmid (48) and 25 ng of pRL-TK (Pro-
mega), along with the indicated protein expression vector using Fugene 6 as
described above. At 24 h posttransfection, the medium was replaced with fresh
medium. At 40 h posttransfection, the cells were either treated with 10 g of
poly(I-C) (GE Healthcare)/ml or PBS for 6 h, and luciferase assays were per-
formed by using a dual luciferase assay kit (Promega). For the porcine IFN--
luciferase assay, 3D4/31 cells were transfected with 0.4 g of porcine IFN--luc
plasmid and 10 ng of pRL-TK (Promega), along with the indicated protein
expression vectors using Ingenio electroporation solution (Miru Bio) in an
Amaxa Nucleofector (Lonza) according to the manufacturer’s instructions.
Then, at 40 h posttransfection, the cells were either mock infected or infected
with SeV (Cantell strain) for 8 h, after which the cells were lysed, and luciferase
assay was performed. Firefly luciferase activities were expressed in terms of the
fold change with respect to controls after normalization with the Renilla lucif-
erase activities.
Real-time PCR and enzyme-linked immunosorbent assay (ELISA). Total
RNA was isolated from cells by using TRIzol (Invitrogen) reagent and cDNA
was prepared by using Moloney murine leukemia virus reverse transcriptase
(Invitrogen). This cDNA was used for quantification of the indicated mRNA
copy number by using SmartCycler (Cepheid). Porcine IFN-, IFN-, and -ac-
tin (internal control) real-time PCR was performed using a TaqMan probe based
method. Human interleukin-8 (IL-8) and human ribosomal protein L32 (RPL32,
internal control) copy numbers were calculated by Sybr-green based quantitative
PCR. The following primer sets and, where indicated, probes were used in the
real-time PCRs. For porcine IFN-, we used forward primer 5-AGAGCCTCC
TGCACCAGTTCT-3, reverse primer 5-CTGCATGACACAGGCTTCCA-3,
and probe 5-ACTGGACTGGATCAGCAGCTCAGGGA-3; for porcine -ac-
tin, we used forward primer 5-CTCCTTCCTGGGCATGGA-3, reverse primer
5-CCACGTCGCACTTCATGATC-3, and probe 5-TGCGGCATCCACGAG
ACCACCT-3; and for human IL-8, we used forward primer 5-TAGCCAGG
ATCCACAAGTCC-3 and reverse primer 5-GCTTCCACATGTCCTCACAA-
3. The primer and probe sequences for swine IFN- (17) and human RPL-32
(33) were as described earlier. IFN-, IFN-, and IL-8 mRNA levels in virus-
infected or poly(I-C)-stimulated cells were expressed in copy numbers relative to
mock-infected or unstimulated cells according to the method described earlier
(51). The porcine IFN and human IL-8 mRNA levels were normalized across the
experiments using porcine -actin and human RPL-32 levels, respectively. Por-
cine IFN- protein levels were measured by ELISA using F17 monoclonal
antibody (MAb; PBL Biomedical Labs) and peroxidase-conjugated K9 MAb
(PBL Biomedical Labs) as coating and detection antibodies, respectively, as
described previously (29). Briefly, flat-bottom 96-well plates were coated over-
night at 4°C with F17 at a concentration of 2 g/l in bicarbonate coating buffer
(pH 9.6). After blocking with 1% bovine serum albumin, for 1 h at 37°C, the
plates were washed three times with 0.05% Tween 20 in PBS. Samples (100 l)
were added into each well, followed by incubation for 4 h at 37°C. After three
washes, 100 l of peroxidase-conjugated K9 at a concentration of 0.5 g/ml was
added to each well. After 2 h of incubation and three washes, 100 l of tetra-
methylbenzidine (TMB) substrate solution was added for 30 min, the reaction
was stopped with 1 N HCl, and the optical density was measured at a 450-nm
wavelength by an ELISA plate reader (Bio-Tek). Quantified recombinant por-
cine IFN- (R&D Systems) was used as a standard, and IFN- concentrations
were calculated based upon a standard curve.
Immunoblotting. For immunoblotting, cells were washed twice with PBS and
then pelleted by centrifugation. In the case of isolation of a nuclear fraction,
these pellets were processed as described previously (45). For whole-cell protein
extraction, PBS-washed cell pellets were resuspended in lysis buffer (20 mM Tris
[pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM
sodium pyrophosphate, 1 mM -glycerophosphate, 1 mM sodium orthovanadate,
complete protease inhibitor [Roche]). The cell suspension was incubated on ice
for 15 min, followed by clarification by centrifugation at 17,000  g at 4°C for 10
min. The total protein concentrations in the supernatants were quantified by
using a Bradford assay kit (Bio-Rad). Equal amounts of total protein were
separated by SDS-PAGE, transferred to polyvinylidene difluoride membrane,
and probed with appropriate antibodies. Protein bands were detected by using an
ECL detection system (Pierce).
Plasmids and antibodies. All PRRSV (FL-12 strain) NSPs were amplified by
using pFL12 (56) as a template and the primers as listed in Table 1. Since the
exact site of cleavage between NSP1 and NSP1 is not known, the putative
cleavage site (nucleotides [nt] 678 to 692) was included in both expression
constructs. The NSP1 and NSP1 expression constructs contain the FL12
(GenBank accession no. AY545985) coding sequence from nt 192 to 710 and nt
651 to 1340, respectively. They were cloned into a mammalian expression vector
pIHA-FLAG, which was derived from pHyg-EGFP (Clontech) by removing the
Hygro-EGFP part and inserting an oligonucleotide containing 5 FLAG epitope
tag and a few restriction enzyme sites to enable the expression of an N-terminal
FLAG-tagged gene. NSP1 was cloned in the same vector but with an N-
terminal hemagglutinin (HA) tag. Porcine IFN--luciferase plasmid was con-
structed by placing porcine IFN- promoter (from nt 	281 to 
 19; the 
1
position refers to the transcription start site of swine IFN- gene GenBank
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accession no. M86762.1) upstream of the firefly luciferase gene in a pGL3-Basic
vector (Promega). pIFN--CAT (44), pISG56-luc (45), p5X-NF-B-luciferase,
pEFBOS-N-RIG-I (52), pmyc-IKKε (53), pHA-TRIF (23), and pCMV2C-bICP0
(44) were described previously. Immunoblotting and indirect immunofluores-
cence were performed with the following antibodies: anti-FLAG M2 MAb
(Sigma), anti-HA MAb (Covance), anti--actin MAb (Santa Cruz Biotech),
rabbit anti-IRF3 polyclonal antibody (pAb) (obtained from Michael David, Uni-
versity of California at San Diego), rabbit anti-ISG56 pAb (19), anti-IRF3-p396
MAb (Cell Signaling), rabbit anti-DRBP76 (45), anti-tubulin MAb (Santa-Cruz
Biotech), and peroxidase-conjugated goat anti-mouse and goat anti-rabbit pAbs
(KPL). Protein bands were visualized by using ECL Plus Western blotting de-
tection reagent (Pierce), followed by exposure to X-ray film.
Indirect immunofluorescence. Cells grown in coverslips were treated as indi-
cated, washed with PBS twice, and then fixed with 4% paraformaldehyde for 20
min at room temperature. After two washes in PBS, the cells were then perme-
abilized with 0.2% Triton X-100 for 15 min and blocked in PBS containing 3%
bovine serum albumin, 5% glycine, 10% nonimmune horse serum, and 0.05%
Tween 20 for 2 h at room temperature. The coverslips were then incubated with
a rabbit polyclonal antiserum against human IRF3 (1:500) or with anti-HA tag
MAb (1:1,000) in the same blocking buffer at 4°C overnight. After three PBS
washes, coverslips were incubated with Alexa Fluor 568-labeled donkey anti-
mouse (Invitrogen) and Alexa Fluor 488-labeled goat anti-rabbit (Invitrogen)
antibodies at room temperature for 1 h. The coverslips were washed and treated
with DAPI (4,6-diamidino-2-phenylindole) to view the nuclei (Sigma), followed
by washing. The coverslips were then mounted in aqueous mounting medium
(Sigma) and observed under Olympus FV500/IX81 inverted confocal micro-
scope.
RESULTS
PRRSV inhibits type I IFN induction. PRRSV has been
found to inhibit IFN induction (1, 29, 36). In order to confirm
and characterize this feature of PRRSV in a well-known
model, we used our well-characterized, infectious clone-de-
rived PRRS virus strain, FL12 (27, 56), corresponding to a
highly virulent North American PRRSV strain (NVSL no.
97-7895). The FL12 virus strain has been extensively used in
our laboratory for studies on virulence and immune response
in infected animals (3, 11, 27, 56). The FL12 strain was used at
a multiplicity of infection of 1.0 to infect macrophages derived
from monocytes isolated from the peripheral blood mononu-
clear cells of healthy pigs. Transmissible gastroenteritis virus
(TGEV), a well-known inducer of type I IFN, was used as a
positive control for type I IFN induction. As shown in Fig. 1,
very little or no IFN- (Fig. 1A) or IFN- (Fig. 1B) mRNA was
detected in the cells infected with PRRSV, whereas TGEV
infection showed strong induction of IFN- and IFN- mRNA
in the same types of cells at both 9 and 18 h postinfection (p.i.).
This observation was confirmed at the protein levels by mea-
suring porcine IFN- in infected cell culture supernatants by
ELISA (Fig. 1C). Productive PRRSV infection in these cells
was confirmed by an immunofluorescence assay conducted at
24 h p.i. using the monoclonal antibody SDOW-17, which is
specific for PRRSV nucleocapsid protein (data not shown).
Similar differences in the type I IFN induction were observed
between PRRSV and TGEV infections in pulmonary alveolar
macrophages obtained from lung lavage of adult animals (data
not shown).
Several of the PRRSV NSPs exhibit strong to moderate
inhibition of IFN- promoter activation. Viruses have been
known to code for proteins that antagonize the type I IFN
response (7). It has been hypothesized that the poor induction
of type I IFN by PRRSV may be an active pathogenic process
triggered by the virus when infecting the host (1). To investi-
gate the role of PRRS viral proteins in active IFN antagonism,
we focused on NSPs of PRRSV. NSPs comprise almost 80% of
the PRRSV genome coding capacity. All of the PRRSV NSPs,
except NSP6 (a very short peptide of 16 amino acids) derived
from the viral genome (FL12 strain), were cloned as N-termi-
nal tagged fusion protein in a mammalian expression vector
and verified for expression by transient transfection and im-
TABLE 1. Primers used to generate individual NSP-expressing plasmids
Primer Sequence (5–3)a Genomic positionb
NSP1F ATATATCTCGAGATGTCTGGGATACTTGATCGG 192–212
NSP1R ATATATGCGGCCGCTTAAAAGTCTTCAGGCTTA 694–710
NSP1F ATATATGCTAGCATGTACCCATACGATGTTCCAGATTACGCTGGAGCAACTCATGTGC 651–666
NSP1R ATATATGCGGCCGCTTAACCGTACCATTTGTGACTGC 1321–1340
NSP2F ATATATACGCGTGCTGGAAAGAGAGCAAGGAA 1341–1360
NSP2R ATATATGCGGCCGCTTAGCCCAGTAACCTGCCAAGA 4261–4280
NSP3F ATATATCTCGAGGGGGCACGCTACATCTGGC 4281–4299
NSP3R ATATATGCGGCCGCTTACTCAAGAAGGGACCCAAGC 5599–5618
NSP4F ATATCTCGAGATGGGCGCTTTCAGAACTC 5619–5634
NSP4R TATATCTAGATCATTCCAGTTCGGGTTTG 6214–6230
NSP5F ATATATCTCGAGGGAGGCCTCTCCACCGTC 6231–6248
NSP5R ATATATGCGGCCGCTTACTCGGCAAAGTATCGC 6724–6740
SP7F ATATATCTCGAGTCGCTGACTGGTGCCCTC 6788–6806
NSP7R ATATATGCGGCCGCTTATTCCCATTGGTTTTTTTTGCTC 7543–7565
NSP8F ATATATCTCGAGGCTGCGAAGCTTTCCGTG 7566–7583
NSP8R ATATATGCGGCCGCTTACTTAGTCAGGCCCTGGA 7665–7683
NSP9F ATATATCTCGAGGGAGCAGTGTTTAAACTGCTAGC 7684–7706
NSP9R ATATATGCGGCCGCTTACTCATGATTGGATCTGAGTTTTTC 9595–9619
NSP10F ATATATCTCGAGGGGAAGAAGTCCAGAATGTG 9620–9639
NSP10R ATATATGCGGCCGCTTATTCCAGATCTGCACAAATG 10923–10942
NSP11F ATATCTCGAGATGTCGAGCTCCCCGCTC 10946–10960
NSP11R TATATCTAGATCATTCAAGTTGAAAATAGGC 11593–11611
NSP12F ATATATCTCGAGGGCCGCCATTTCACCTGGTA 11612–11631
NSP12R ATATATGCGGCCGCTTATCAATTCAGGCCTAAAGTTGGTTC 12049–12073
a The restriction enzyme sites used for cloning are underlined. The N-terminal HA tag in the NSP1F primer is indicated in boldface.
b The genomic positions for the primers are based on GenBank accession number AY545985.
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munofluorescence in HeLa cells. We were able to obtain sat-
isfactory expression levels for 10 NSPs (data not shown). We
failed to achieve high-level expression for NSP3, which may be
due to its instability when expressed alone, since it has been
most often reported to be part of polyprotein complex consist-
ing of other NSPs in case of equine arteritis virus (EAV), the
prototypic family member of Arteriviridae (41). Each of these
NSP constructs was cotransfected into HeLa cells, along with
IRF3 and human IFN--CAT constructs, and CAT assays were
performed. As shown in Fig. 2A, IFN- promoter activation by
IRF3 was suppressed to various degrees by NSP1, NSP2,
NSP4, and NSP11. NSP1 exhibited the strongest inhibitory
effect, followed by others (Fig. 2A). The bovine herpesvirus
protein bICP0 was used as a positive control, which is known to
inhibit IFN- promoter induction by IRF3 (44). This result
suggested that several of the PRRSV NSPs are capable of
suppressing IFN- promoter activation. To confirm this inhi-
bition of IFN- promoter activation, we cotransfected increas-
ing concentrations of each of the corresponding NSP plasmids
into HeLa cells by using the same assay. Figure 2B shows the
dose-dependent inhibition of IFN- promoter activity with in-
creasing concentrations of NSPs (Fig. 2B, bottom panel).
PRRSV NSP1 and NSP11 inhibit IRF3-mediated gene in-
duction. Viral nucleic acids are detected by the host innate
immune system using Toll-like receptors (TLR) and RIG-like
receptors (RLR). One such unique nucleic acid is dsRNA, a
common by-product or intermediate in viral genome replica-
tion. In mammals, TLR3, retinoic acid inducible gene I (RIG-
I), and melanoma differentiation-associated gene 5 (MDA5)
are the three known sensors of dsRNA. Engagement of TLR3
or RLR with dsRNA induces signaling cascades, leading to the
activation of multiple transcription factors such as NF-B and
IRF3. These activated transcription factors induce the expres-
sion of a set of cytokine genes, among which are type I IFNs,
the hallmark of the antiviral response. IFNs signal via cell
surface receptors and regulate many genes (IFN-stimulated
genes [ISGs]) which sensitize cells for detection of invading
pathogens, inhibit protein synthesis, and limit viral replication
(46). We used dsRNA-mediated TLR3 activation and IFN
induction as a model system to understand the mechanism of
IFN antagonism by PRRSV NSPs. We decided to focus on
NSP1 and NSP11 since they consistently exhibited the strong
inhibition property (Fig. 2B). NSP1 is proteolytically processed
during the infection by its own papainlike protease domain
into NSP1 and NSP1. Therefore, the three proteins
(NSP1, NSP1, and NSP11) were tested for their IFN antag-
onistic activity using an ISG56-luciferase reporter assay. Un-
like a complex promoter such as IFN-, the ISG56 promoter
FIG. 1. Inhibition of type I IFN production after PRRSV infection. Porcine monocyte-derived macrophages were mock infected or infected
with PRRSV (FL-12) or TGEV at a multiplicity of infection of 1. Supernatants and cells were collected after 9 and 18 h p.i., respectively. Total
RNA isolated from cells was reverse transcribed, and real-time PCR was performed for the detection of porcine IFN- (A) and IFN- (B) mRNA.
The mRNA copy numbers were calculated after normalization with the -actin copy number and are expressed as percentages relative to the mock
control. Bars show the average of mRNA copy numbers  the standard error of the mean (SEM) from three independent experiments using cells
isolated from three different pigs. (C) Supernatants from the same experiments were used to detect secreted IFN- by ELISA. Quantified
recombinant porcine IFN- was used as a standard, and IFN- levels were calculated based upon a standard curve.
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has a simpler structure and can be activated by IRF3/IRF7.
HEK293 cells stably expressing human TLR3 (HEK293-
TLR3) were used in order to focus on the TLR3-IRF3 arm of
the dsRNA signaling pathway. These cells were cotransfected
with the NSP expression constructs, ISG56-luciferase, and Re-
nilla-luciferase vectors. At 40 h after transfection, the cells
were stimulated with dsRNA for 6 h, followed by a luciferase
assay. As expected, all of the three proteins showed significant
downregulation of dsRNA-mediated ISG56 promoter activa-
tion compared to an empty vector control (Fig. 3A).
For a more direct confirmation of the inhibition of dsRNA
signaling by these proteins, we established HEK293-TLR3 cell
lines stably expressing these three PRRSV NSPs. Upon treat-
ment with dsRNA, these cell lines induced no or very low levels
of endogenous ISG56 compared to the empty vector-express-
ing cells (Fig. 3B, C, and D). A different dsRNA-responsive
cell line, HT1080 (a human fibrosarcoma cell line), stably ex-
pressing these viral proteins also showed similar results upon
dsRNA treatment (data not shown). This indicates that the
inhibitory effect observed is independent of the cell line being
used. Taken together, our results from two different assays
suggest that PRRSV NSP1, NSP1, and NSP11 are involved
in the inhibition of IRF3-mediated IFN signaling.
PRRSV NSP1 inhibits NF-B-mediated gene induction. In
addition to IRF3, the TLR3 signaling pathway also activates
NF-B. The next series of experiments were directed to inves-
FIG. 2. Specific PRRSV proteins are involved in downregulation of IFN- promoter. (A) HeLa cells were cotransfected with pIFN--CAT
plasmid (1 g), IRF3 expression plasmid (0.5 g), and the viral nonstructural protein expression plasmids (1 g) or bovine herpesvirus type 1
protein bICP0. Empty vector was added to the transfection mixture to keep the total DNA amount constant. Cell extracts collected at 40 h
posttransfection were analyzed for CAT activity as described in Materials and Methods. The value of the CAT activity in the presence of empty
vector was set at 100%, and those of the viral proteins were normalized accordingly. (B) Increasing amounts of indicated NSP coding plasmids were
transfected, and CAT activities were measured as described earlier. The bars represent the means the SEM from three independent experiments.
The bottom panels show increasing levels of individual NSP expression upon transfection (actin was used as a loading control).
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tigate the effect of these NSPs on NF-B-mediated gene in-
duction by dsRNA. Cells were cotransfected with NSPs, along
with 5X-NF-B-luciferase and Renilla luciferase reporters.
Upon dsRNA treatment, the empty vector-transfected cells
showed strong induction of luciferase activity compared to the
untreated cells. Expression of NSP1 and NSP11 downregu-
lated the induction of luciferase activity to the level of the
untreated control (Fig. 4A). Interestingly, NSP1 expression
did not have a significant negative effect on NF-B promoter
activity. This suggests differential inhibition of NSP1 com-
pared to NSP1 and NSP11. To confirm the negative effect of
NSP1 on NF-B signaling, we assessed the induction of en-
dogenous IL-8 mRNA, a cytokine whose expression is princi-
pally driven by NF-B. In accordance with the reporter assay
result, IL-8 mRNA induction upon dsRNA treatment was sig-
nificantly reduced in HEK293-TLR3 cells stably expressing
NSP1 compared to empty vector control cells (Fig. 4B).
TRIF or IKK do not rescue NSP1-mediated inhibition of
IRF3 activation. Besides TLR3, cytoplasmic dsRNA is sensed
by DExD/H box RNA helicases: RIG-I and MDA5 (24). A
number of RNA viruses induce signaling through dsRNA re-
ceptor RIG-I (30). Having established that PRRSV NSP1
inhibits TLR3-mediated IRF3 and NF-B signaling, we inves-
tigated the effect of NSP1 on RIG-I signaling pathways. We
took advantage of expressing the N-terminal CARD domain of
RIG-I, which constitutively activates the RIG-I signaling path-
way (14), and tested the effect of NSP1. As shown in Fig. 5A,
the constitutively active RIG-I, when coexpressed with ISG56-
luciferase, induced strong luciferase activity compared to the
vector control. However, in the presence of NSP1 the induc-
tion is completely inhibited showing that, in addition to the
TLR3 pathway, NSP1 also inhibits the RIG-I-mediated sig-
naling pathway.
Oftentimes, a very similar approach is used to identify the
step(s) of the signaling pathway that is being inhibited (33). We
used expression constructs for TRIF and IKKε, two major
components of TLR3 signaling pathway, to examine whether
the NSP1-mediated inhibition could be rescued. Our results
show that IRF3 activity was induced by transfection of TRIF
(Fig. 5B) and IKKε (Fig. 5C) in an ISG56-luciferase reporter
assay. The presence of NSP1 significantly downregulated the
ISG-56 promoter activation induced by these molecules. These
results indicate that part of the inhibitory activity of NSP1
affects the downstream signaling of IRF3 kinases, probably by
directly affecting IRF3. Exogenous expression of TRIF could
not recover activation of a NF-B-dependent promoter in the
presence of NSP1 either (data not shown).
NSP1 inhibits dsRNA-induced IRF3 phosphorylation and
nuclear translocation. In the resting state, IRF3 shuttles be-
tween the cytoplasm and the nucleus. Activation by dsRNA
causes its phosphorylation and translocation to the nucleus
(58). The binding and recruitment of IRF3 on ISRE promoters
is stabilized by CBP/p300, which prevents its export from the
nucleus. To investigate the mechanism of NSP1-mediated
inhibition of IRF3 activation, we assayed several hallmark
steps of the IRF3 activation process, such as IRF3 phosphor-
ylation (on Ser396) and nuclear translocation, upon dsRNA
treatment. As expected, dsRNA treatment induced a marked
increase in the level of phosphorylated IRF3 in the control
cells. However, in NSP1-expressing cells, IRF3 phosphoryla-
tion was reduced to the basal level (Fig. 6A). IRF3 nuclear
translocation was similarly affected by NSP1 expression. As
FIG. 3. Inhibition of IRF3-mediated gene induction by PRRSV proteins. (A) HEK-293TLR3 cells were cotransfected with the indicated viral
NSP expression plasmids (1 g) or empty vector, ISG56-luciferase plasmid (0.4 g), and pRLTK (0.01 g). At 40 h posttransfection the cells were
treated with 10 g of dsRNA/ml or PBS for 6 h and assayed for luciferase activity. The bars represent the average fold inductions  the SEM for
luciferase activities compared to PBS-treated vector control. The panel below the bar graph shows the expression of the respective NSPs. The
asterisk (*) at NSP1 lane indicates the detection of proteolytically processed NSP1 to NSP1, which carries the N-terminal FLAG tag. (B to D)
HEK293-TLR3 cells stably expressing NSP1 (B), NSP1 (C), and NSP11 (D) (lanes 4 to 6) were stimulated with the indicated amount of dsRNA
for 6 h, and the ISG56 level was measured by immunoblotting and compared to empty vector-transfected, puromycin-resistant control cells (lanes
1 to 3). Expressions of NSPs were detected by probing with anti-FLAG/HA antibody.
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shown in Fig. 6B, the level of IRF3 present in the nuclear
fraction increased upon dsRNA treatment. However, in the
presence of NSP1 IRF3 failed to translocate to the nucleus.
This was consistent with the previous result showing the re-
duction of IRF3 phosphorylation in the presence of NSP1.
This phenomenon was further verified by visualization of the
subcellular location of IRF3 by indirect immunofluorescence.
HEK293-TLR3 cells transfected with empty vector showed
efficient IRF3 nuclear translocation 2 h after dsRNA treatment
but, in the presence of NSP1, most of the IRF3 was retained
in the cytoplasm (Fig. 6C) in a manner similar to empty vector-
transfected cells without dsRNA treatment (top left panel).
FIG. 4. Inhibition of NF-B-mediated gene induction by PRRSV proteins. (A) HEK293-TLR3 cells were cotransfected with the indicated viral
NSP expression plasmids or empty vector (1 g), 5X NF-B-luciferase plasmid (0.5 g), and pRLTK (0.025 g). At 40 h posttransfection the cells
were treated with dsRNA for 6 h and assayed for luciferase activity. The fold induction of the average luciferase activity compared to the untreated
vector control from a representative experiment is shown. The immunoblot panel indicates the expression of individual NSPs in the luciferase assay.
(B) IL-8 mRNA levels were measured by real-time PCR in HEK293-TLR3 cells stably expressing NSP1 or vector control cells with or without
dsRNA treatment. The mRNA copy numbers were calculated after normalizing them with the RPL32 (internal control) copy number and are
expressed as percentages relative to the uninduced vector control.
FIG. 5. NSP1 inhibits IRF3 signaling by acting downstream of IRF3 kinases. HEK293-TLR3 cells were cotransfected with ISG56-luciferase
plasmid, NSP1 expression plasmids, or empty vector. IRF3 signaling pathway was induced by including in the transfection constitutively active
RIG-I (A), TRIF (B), and IKKε (C). Cells were lysed 40 h posttransfection and assayed for luciferase activity. Bars indicate the mean fold
inductions  the SEM of luciferase activity compared to the vector control from three independent experiments.
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These results suggest that NSP1 inhibits dsRNA-mediated
phosphorylation of IRF3 and its nuclear translocation.
NSP1 inhibits SeV-induced IFN- promoter activation. To
establish the innate immune evasion property of NSP1 in a
physiological context, we tested SeV-mediated ISG56 induc-
tion in NSP1-expressing cells. The innate immune response
against SeV infection is primarily mediated by RIG-I (30). We
tested SeV-mediated ISG56 induction in NSP1-expressing
cells. HEK293-TLR3 cells stably expressing NSP1- or empty
vector-transfected control cells were either mock infected or
infected with SeV (40 HA unit/ml) for 8 h. As shown in Fig.
7A, the presence of NSP1 significantly inhibited SeV-medi-
ated ISG56 induction compared to control cells. Finally, to
replicate the effect of NSP1 on porcine IFN- induction, we
used the porcine monocytic cell line 3D4/31. This myelomono-
cytic cell line has been recently characterized to support
PRRSV replication and infectious virus production upon
transfection with PRRSV genomic RNA, but it lacks the nec-
essary receptor in order to enable spread of virus from cell to
cell (22). The 3D4/31 cells were transfected by electroporation
with porcine IFN--luciferase reporter and NSP1 or NSP1.
SeV infection of vector-transfected cells showed induction of
porcine IFN--luciferase activity. However, in the presence of
NSP1 or NSP1, porcine IFN--luciferase activity was inhib-
ited in a dose-dependent manner (Fig. 7B). This result con-
firms our findings that NSP1 plays a crucial role in innate
immune evasion function of PRRSV in a physiologically rele-
vant environment.
FIG. 6. NSP1 inhibits dsRNA-induced IRF3 phosphorylation and nuclear translocation. (A) HEK293-TLR3 cells stably expressing NSP1-
or vector-transfected cells (vector) were either mock treated or treated with dsRNA for 2 h. Phosphorylated IRF3 (pIRF3) and total IRF3 levels
were measured by immunoblotting. (B) Nuclear fractions (N.P) from HEK293-TLR3 cells stably expressing NSP1 either mock treated or treated
with dsRNA were blotted for IRF3. DRBP76 and tubulin are markers for nuclear and cytoplasmic fractions, respectively. WCE, whole-cell extract.
(C) IRF3 subcellular localization was determined by confocal microscopy in HEK-293TLR3 cells stably transfected with empty vector (vector) or
NSP1 after dsRNA stimulation. For this purpose, cells were either treated or left untreated with 100 g of dsRNA/ml for 2 h, followed by
immunofluorescence for endogenous IRF3 (green) and NSP1 (red) with rabbit anti-IRF3 and mouse anti-HA antibody, as indicated at the top
of the panel. Position of nucleus is indicated by DAPI (blue) staining in the merge image.
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DISCUSSION
Viruses have developed a number of mechanisms to subvert
or prevent IFN induction and response (7). In the case of
PRRSV, both North American and European PRRSV strains
have been shown to be poor inducers of IFN in vitro and in
vivo. Infection of PAMs with the North American prototype
PRRSV VR-2332 significantly reduced their ability to produce
type I IFN (36, 37). Furthermore, the absence of IFN- pro-
duction in TGEV-infected swine alveolar macrophages, which
had been previously infected with PRRSV, implicates an active
inhibition of IFN production by PRRSV. In summary, all of
the studies are consistent with the fact that PRRSV exerts an
active suppression of type I IFN response. In agreement with
these, we have shown here that PRRSV infection of monocyte-
derived macrophages showed inhibition of IFN- and IFN-
production both at the mRNA and the protein levels. Our data
show that five PRRSV NSPs—the NSP1, NSP1, NSP2,
NSP4, and NSP11—have roles in IFN antagonism and inhibit
activation of the IFN- promoter.
In the present study we used TLR3- and RIG-I-mediated
dsRNA signaling pathways as model systems to understand the
mechanism of innate immune evasion by PRRSV. NSP1,
NSP1, and NSP11, when stably expressed in HEK293-TLR3
cells, were able to inhibit upregulation of endogenous ISG56
by dsRNA. Moreover, stable expression of NSP1 inhibited
endogenous ISG56 induction by SeV. Investigation of IRF3
phosphorylation status after dsRNA stimulation showed that
NSP1 inhibits IRF3 (Ser396) phosphorylation and subse-
quent nuclear translocation. Although the biochemical nature
of this inhibition by PRRSV NSP1 remains to be character-
ized, there are several mechanisms by which different viruses
have been shown to inhibit IRF3 activation. Certain paramyxo-
viral V proteins interact with IKKε/TBK1 and function as a
competitive inhibitor for IRF3 phosphorylation (33). The W
protein of Nipah virus specifically interacts with karyopherin
3 and 4 through its nuclear localization signal and prevents
IRF3 translocation (47). It has been reported that NSP2 of
EAV, the prototypic member of Arteriviridae family, antago-
nizes host innate immune response by deconjugating ubiquitin
and ISG15 from their cellular substrates (15). Therefore, it is
possible that NSP1, a member of cysteine protease family
that includes most deubiquitinases, might also use a similar
strategy of deconjugating important ubiquitin modifications of
IRF3 or RIG-I (6). All of these possible mechanisms of inhi-
bition of dsRNA signaling by NSP1 are currently under in-
vestigation.
NSP1 and NSP11 expression also inhibited transcription
from an NF-B-responsive promoter, but NSP1 expression
has no inhibitory effect. The suppressive role of NSP1 in
NF-B-mediated signaling was further evident from the low
level of IL-8 induction in dsRNA-treated HEK293-TLR3 cells
stably expressing NSP1. This finding contradicts a previous
report that found PRRSV infection of MARC-145 cells and
alveolar macrophages resulting in the activation of the NF-B
pathway through the degradation of IB (28). The disagree-
ment might be due to the fact that the NF-B activation in that
study was assayed at a late phase of virus infection (24 to 48 h
after virus infection). The activation of NF-B is an immedi-
ate-early event that occurs within minutes after exposure to a
stimulus and results in a strong transcriptional stimulation of
several cytokines (21). Considering that the PRRSV replica-
tion cycle in macrophages is completed by 12 h, this effect may
be a secondary effect of virus infection. Inhibition of NF-B
pathway by PRRSV NSPs, especially during the early infection
phase, would help the virus not only to subvert the host innate
immune response but also to produce enough progeny virus
before being released by apoptosis as proposed by others (10).
PRRSV NSP1 contributes two accessory proteinases NSP1
and NSP1 for the processing of replicase polyprotein. NSP1
and NSP1 both possess two papainlike cysteine protease
(PCP) domains, PCP and PCP, which mediate the release of
NSP1 and NSP1 from the polyproteins (12). Previous re-
verse genetics experiments showed that PCP activity is essen-
FIG. 7. NSP1 and NSP1 inhibit SeV-induced porcine IFN- pro-
moter activation and human ISG56 induction. (A) HEK293-TLR3
cells stably transfected with empty vector (vector) or NSP1 were
either mock infected or infected with SeV (40 HA units/ml) for 8 h.
Endogenous ISG56 levels were detected by immunoblotting. NSP1
protein was detected by anti-HA antibody. (B) Porcine monocytic cells
(3D4/31 cell line) were cotransfected with increasing concentrations of
NSP1/NSP1 expression plasmids or empty vector (vector), along with
porcine IFN--luciferase plasmid (0.4 g) and pRLTK (0.01 g). At
40 h after the transfection cells were either mock infected or infected
with 80 HA units of SeV/ml for 8 h and assayed for luciferase activity.
Bars indicate the average fold induction of luciferase activities  the
SEM compared to uninfected vector control cells. The bottom panel
shows immunoblots for the level of each NSP expression in respective
transfection. The asterisk indicates detection of N-terminally FLAG-
tagged NSP1, the cleavage product of NSP1.
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tial for subgenomic mRNA synthesis but dispensable for ge-
nome replication. However, mutation of active-site residues of
PCP resulted in no genome replication and a failure in virus
recovery after electroporation of in vitro-transcribed RNA, un-
derscoring its important role (26). Whether the NSP1 active
site residues (Cys and His) are involved in its IFN antagonistic
activity in the context of whole virus infection remains to be
investigated. However, it may not be feasible to structurally
separate proteolytic function of NSP1 from its IFN antago-
nistic function because of the general multifunctional nature of
viral proteins. This multifunctional nature of NSP1 has been
already established in EAV, and it has been found that the
structural integrity of NSP1 is essential for transcription (54,
55). In such case, given the essential function of PRRSV
NSP1 in virus viability, it may not be possible to recover by
reverse genetics a replication-capable virus that lacks anti-IFN
activity.
The inadequate immunological response to PRRSV infec-
tion is underscored by the fact that an infected animal exhibits
prolonged viremia, persistent infection, and continuous virus
shedding. The poor type I IFN production at the site of
PRRSV infection (e.g., lungs) has long been considered the
root cause behind defective or suboptimal initiation and elab-
oration of the antigen-specific adaptive immune response (1,
35). Influenza virus carrying truncated nonstructural 1 (NS1)
protein, which counteracts the host type I IFN response, is
highly attenuated in mice, swine, and chicken models (42, 50).
Another important example of correlation between anti-IFN
activity and virulence is Ebola virus VP35 protein, which in-
hibits IRF3 activation. Single amino acid mutation (R312A) of
VP35 protein, which compromises its ability to inhibit IRF3
activation, renders the virus highly attenuated in mice (20). It
is possible that the strong anti-IFN activity of the NSPs of
PRRSV may have a direct effect in the paradoxical immune
response observed in PRRSV infection and would explain the
inability of the host to clear PRRSV. Such an important im-
munomodulatory effect of these NSPs may also be the basis for
the pathogenesis and virulence of this virus. On the other
hand, pestiviruses, which include classical swine fever virus
(CSFV) and bovine viral diarrhea virus, have been shown to
induce proteasomal degradation of IRF3 by the viral autopro-
tease Npro, which subsequently inhibits IFN-/ production
(4, 18). A recent investigation into the correlation between the
ability of CSFV for IRF3 degradation and viral virulence found
that impairment of the IFN antagonistic activity did not give
rise to an attenuated virus (43). The authors of that study
suggest that the inhibition of type I IFN may have a role in
longer persistence of the virus in pigs. Previous results from
our laboratory indicated that viral NSP3-8 might play a major
role in PRRSV virulence (27). Taken together with our find-
ings reported here, this suggests that the pathogenesis of
PRRSV may be a complex summation of several major effec-
tors contributing to the overall pathogenesis of PRRSV. The
NSP1 acts as a suppressor of innate immune response, and
NSP3-8 determines the virulence and invasive capacity, which
helps the virus to translocate and cross placenta and infect
fetuses. Highly pathogenic viruses such as SARS-CoV and
Ebola viruses encode multiple proteins targeting different
steps in IFN signaling. This not only ensures complete inhibi-
tion of the IFN response but also provides a fail-safe mecha-
nism for the virus in case a single protein became dysfunc-
tional. Our current findings that five NSPs of PRRSV are
involved in IFN antagonism, though of variable ability, point
toward PRRSV’s pathogenic nature.
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